The CEACAM1-dependent endocytosis of insulin-bound insulin receptors facilitates the degradation of insulin and maintains the normal insulin half-life in the circulation, thereby preventing hyperinsulinemia and systemic insulin resistance. The gene discussed is CEACAM1; the disease is hyperinsulinism.